威胜信息技术股份有限公司2025 年年度报告摘要 公司代码：688100 公司简称：威胜信息 威胜信息技术股份有限公司 2025 年年度报告摘要 威胜信息技术股份有限公司2025 年年度报告摘要 第一节 重要提示 1、 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规 划，投资者应当到 www.sse.com.cn 网站仔细阅读年度报告全文。 2、 重大风险提示 公司已在本年度报告中详细描述可能存在的风险，敬请查阅本报告第三节"管理层讨论与分 析"之"四、风险因素"中的内容。 3、 本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 4、 公司全体董事出席董事会会议。 5、 天健会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 6、 公司上市时未盈利且尚未实现盈利 □是 √否 7、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 根据《上市公司股份回购规则》等有关规定，上市公司回购专用账户中的股份，不享有利润 分配的权利。公司拟以实施权益分派股权登记日登记的 ...

证券代码：688522 证券简称：纳睿雷达 公告编号：2026-011 广东纳睿雷达科技股份有限公司 2025 年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 本公告所载 2025 年度主要财务数据为初步核算数据，未经会计师事务所审计， 具体数据以广东纳睿雷达科技股份有限公司（以下简称"公司"）2025 年年度的定期 报告为准，敬请投资者注意投资风险。 一、2025 年度主要财务数据和指标 单位：人民币万元 | 项目 | 本报告期 | 上年同期 | 增减变动幅度（％） | | --- | --- | --- | --- | | 营业总收入 | 46,012.18 | 34,527.56 | 33.26 | | 营业利润 | 11,121.76 | 8,511.76 | 30.66 | | 利润总额 | 11,077.36 | 7,832.95 | 41.42 | | 归属于母公司所有者的净利润 | 10,846.95 | 7,661.29 | 41.58 | | 归属于母公司所有者的扣除非 经常性损益的净利润 ...

Financial Performance - Total revenue for 2025 was RMB 81,132.52 million, a decrease of 28.94% compared to the previous year[3] - Net profit attributable to the parent company was RMB -3,051.59 million, down 120.65% year-on-year[3] - Net profit attributable to the parent company after deducting non-recurring gains and losses was RMB -5,389.68 million, a decline of 142.98%[3] - Basic earnings per share were RMB -0.22, a decrease of 117.46% compared to the previous year[3] - Operating profit and total profit decreased by 108.10% and 110.26% respectively compared to the previous year[7] Assets and Equity - Total assets at the end of the reporting period were RMB 325,342.98 million, an increase of 1.05% from the beginning of the period[6] - Equity attributable to the parent company decreased by 2.86% to RMB 232,343.58 million[6] Revenue and Profit Decline Factors - The decline in revenue and net profit was primarily due to a decrease in order prices and increased industry competition[6] - The company experienced a significant drop in gross profit margin due to falling order prices[7] Financial Reporting - The financial data presented is preliminary and unaudited, with final results to be confirmed in the 2025 annual report[4]

Financial Performance - The company achieved total operating revenue of RMB 151.51 million, representing an 18.78% year-on-year increase[5] - The net profit attributable to the parent company was a loss of RMB 76.18 million, a 40.00% increase in loss compared to the previous year[5] - The total assets at the end of the reporting period were RMB 2,153.47 million, a decrease of 2.91% from the beginning of the period[5] - The equity attributable to the parent company was RMB 2,036.32 million, down 3.11% from the beginning of the period[5] - The basic earnings per share were -RMB 1.09, compared to -RMB 0.78 in the previous year[5] Research and Development - The company increased its R&D expenses to strengthen its technological advantages in RNA drugs, antibody drugs, and synthetic biology[7] Marketing and Sales - Sales expenses increased as the company expanded its marketing team and focused on overseas market development[7] Business Growth and Challenges - The company faced challenges in the industry but continued to grow its main business revenue through product line expansion and new business development[6] Other Income and Expenses - Government subsidies decreased compared to the previous year, impacting other income[8] - Deferred tax expenses increased due to the cautious approach regarding future taxable income, affecting current profits[9]

Financial Performance - The total operating revenue for 2025 reached CNY 617.89 million, representing a significant increase of 55.94% compared to the previous year[6] - The net loss attributable to shareholders of the parent company was CNY 138.78 million, a reduction of CNY 62.89 million from the previous year's loss[8] - The basic earnings per share improved to CNY -1.75, an increase of CNY 0.78 compared to the previous year[9] - The total loss for the reporting period was CNY 138.78 million, with a total profit loss of CNY 138.78 million, reflecting a narrowing of losses[8] Research and Development - Research and development expenses accounted for approximately 52% of operating revenue, a decrease of about 22 percentage points year-on-year[7] Assets and Equity - Total assets at the end of the reporting period were CNY 1,690.09 million, down 3.09% from the beginning of the period[5] - The equity attributable to shareholders of the parent company decreased by 6.67% to CNY 1,501.28 million[5] Return on Investment - The weighted average return on net assets improved by 2.85 percentage points to -8.94%[4] Market Conditions - The company benefited from the growth in the global semiconductor market and increased sales of various Ethernet PHY chips[6] Reporting Accuracy - There are no significant uncertainties affecting the accuracy of the performance report[10]

Financial Performance - Total operating revenue for 2025 reached RMB 4.13 billion, an increase of 7.87% compared to RMB 3.83 billion in the previous year[3] - Net profit attributable to shareholders of the listed company was RMB 561.75 million, up 19.38% from RMB 470.56 million year-on-year[3] - Basic earnings per share increased to RMB 1.11, reflecting a growth of 5.71% from RMB 1.05 in the previous year[3] - The weighted average return on net assets decreased by 3.23 percentage points to 12.54%[3] Assets and Equity - The company's total assets increased by 11.03% to RMB 6.76 billion from RMB 6.09 billion at the beginning of the period[3] - Shareholders' equity attributable to the listed company rose by 37.63% to RMB 4.37 billion, primarily due to the conversion of convertible bonds and profit growth[7] Business Performance - The compressor parts business saw a significant improvement in profitability due to optimized product structure and operational efficiency[7] - The automotive parts business experienced a gradual increase in production and sales through the integration of new capacities from a joint venture[7] - The engineering machinery parts business faced short-term sales pressure due to industry downturns[7] Risk Management - The company emphasizes the importance of monitoring investment risks as the reported financial data is preliminary and unaudited[8]

Financial Performance - Total revenue for 2025 reached CNY 1,078.86 million, representing a 71.15% increase compared to the previous year[5] - Net profit attributable to shareholders was CNY 7.04 million, a growth of 108.55% year-over-year[5] - The net profit after deducting non-recurring gains and losses was CNY 42.27 million, reflecting a 157.27% increase from the prior year[5] - Basic earnings per share improved to CNY 0.0167, compared to a loss of CNY 0.2039 in the previous year[5] Assets and Equity - Total assets at the end of the reporting period amounted to CNY 2,837.76 million, up 27.01% from the beginning of the period[7] - Shareholders' equity attributable to the company increased to CNY 1,567.38 million, a rise of 36.86% compared to the start of the period[7] - The increase in shareholders' equity and share capital was primarily due to a stock issuance to specific investors during the reporting period[8] Revenue Drivers - The company attributed revenue growth to increased LNG vehicle sales and a focus on high-margin orders, alongside cost reduction strategies[7] Legal and Compliance - A provision of CNY 61.47 million was made due to a lawsuit, significantly impacting net profit[7] - The company confirmed that there were no discrepancies between the reported earnings and previous forecasts[9]

证券代码：920578 证券简称：巨能股份 公告编号：2026-008 宁夏巨能机器人股份有限公司 2025 年年度业绩快报公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 特别提示：本公告所载 2025 年年度主要财务数据为初步核算数据，未经会 计师事务所审计，具体数据以公司 2025 年年度报告中披露的数据为准，提请投 资者注意投资风险。 （二）业绩变动的主要原因 1、营业收入较上年同期下降的主要原因：受宏观市场环境变化影响，下 游客户投资决策放缓、项目推进及执行周期延长，导致公司本期营业收入较上 年同期下降。 一、2025 年年度主要财务数据和指标 单位：元 | 项目 | 本报告期 | 上年同期 | 变动比例% | | --- | --- | --- | --- | | 营业收入 | 165,501,076.52 | 252,596,168.43 | -34.48% | | 利润总额 | -2,637,538.83 | -1,217,587.39 | -116.62% | | 归属于上市公司股 ...

证券代码：920964 证券简称：润农节水 公告编号：2026-003 河北润农节水科技股份有限公司 2025 年年度业绩快报公告 二、经营业绩和财务状况情况说明 （一）报告期的经营情况、财务状况及影响经营业绩的主要因素 1、报告期内，公司实现营业收入 102,862.06 万元，同比增长 4.58%；归属 于上市公司股东的净利润 381.54 万元，同比下降 52.00%；归属于上市公司股东 的扣除非经常性损益的净利润 256.11 万元，同比下降 45.09%；基本每股收益 0.01 元，同比下降 66.67%。 2、报告期末，公司总资产 159,700.96 万元，同比增长 13.27%；归属于上市 公司股东的所有者权益 89,042.29 万元，同比下降 0.16%；归属于上市公司股东 的每股净资产 3.41 元。 （二）业绩变动的主要原因 1、公司部分已完工或处于执行阶段的存量老项目，存在款项结算进度不及 预期、回款周期明显拉长的情况，基于企业会计准则的谨慎性原则，相应计提的 信用减值损失金额较上年同期有所增加，导致当期净利润有所下降； 2、公司主业所处市场广阔，但面临的市场竞争格局依然激烈，行业整 ...

Financial Performance - The company achieved operating revenue of CNY 307,752,106.30, a year-on-year increase of 4.36%[4] - Net profit attributable to shareholders decreased by 5.45% to CNY 42,096,701.57[4] - The net profit after deducting non-recurring gains and losses was CNY 39,192,628.30, down 5.99% year-on-year[4] - Basic earnings per share were CNY 0.41, a decline of 4.65% compared to the previous year[4] Assets and Equity - Total assets at the end of the reporting period were CNY 628,632,625.56, an increase of 3.94% from the beginning of the period[4] - Shareholders' equity attributable to the company increased by 4.93% to CNY 448,594,523.01[4] - The company’s net asset per share rose to CNY 4.33, reflecting a growth of 4.84% from the beginning of the period[5] Market and Competition - The company's gross profit margin declined due to intensified market competition, impacting net profit[6] - Employee compensation increased compared to the previous period, contributing to the decline in net profit[6] Cautionary Notes - The company emphasizes that the financial data is preliminary and subject to final audit, urging investors to be cautious[7]